Search clinical trials for: Placebo to moxifloxacin

Total 61056 results

Taisho Pharmaceutical Co., Ltd.

Completed

A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

Healthy Subjects

Japan
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomedica; Miquel Ferrer - Investigator Coordinator

Unknown

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response (2017-001406-15)

Community-acquired Pneumonia

Spain
Janssen Research & Development, LLC

Completed

Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants

Healthy

United States
Wockhardt

Completed

Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

Qt Interval, Variation in

United States
National Institute of Allergy and Infectious Diseases...

Completed

Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers

Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Effects of SQ109 on QTc Interval in Healthy Subjects

Tuberculosis

United States
Inje University

Completed

The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects

Healthy
University of Malaya

Unknown

Compare Air Polishing With Ultrasonic During Maintenance

Periodontitis

Malaysia
University of California, San Francisco
National Eye Institute (NEI); Stanford University; Federal University of São... and other collaborators

Active, not recruiting

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction (REAGIR)

Fungal Keratitis | Acanthamoeba Keratitis

Brazil, India
AstraZeneca

Completed

A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects

Amount of NKTR-118 in Blood | Variation in the Heart's Electrical Cycle

United States
Actelion

Completed

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

Healthy

Germany
Verona Pharma plc
Iqvia Pty Ltd; LGC Limited

Completed

Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD

COPD

United States
Gilead Sciences
Galapagos NV

Withdrawn

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy (SEALION1-IR)

Ankylosing Spondylitis
EMD Serono

Terminated

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) (ATAMS)

Relapsing Multiple Sclerosis

United States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Persistent Asthma

United States, Netherlands, United Kingdom, France, Germany, Jordan
Alcon Research

Terminated

A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates

Corneal Infiltrates

United States
Gilead Sciences
Galapagos NV

Withdrawn

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy (SEALION2-NAÏVE)

Ankylosing Spondylitis
Samsung Medical Center

Completed

Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method

Dyspepsia

Korea, Republic of
sigma-tau i.f.r. S.p.A.
Medicines for Malaria Venture

Completed

Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers

Malaria, Falciparum

France
Boehringer Ingelheim

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL

Healthy

Germany
Boehringer Ingelheim

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX

Healthy

Germany
Novartis

Completed

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

Chronic Obstructive Pulmonary Disease

United States
AstraZeneca

Completed

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

Healthy | Memory Impairment

United States
Idorsia Pharmaceuticals Ltd.

Completed

Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

France
Cytokinetics

Completed

Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval

Healthy Participants

United States
Washington University School of Medicine

Withdrawn

Vigamox Treatment for Ocular Graft-Versus-Host Disease

Ocular Graft-versus-host Disease

United States
Achaogen, Inc.
Department of Health and Human Services

Completed

A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

Cardiac Effects in Normal Healthy Volunteers

United States
Alexza Pharmaceuticals, Inc.

Completed

ADASUVE 2-dose Thorough QT/QTc Study

Healthy Volunteers

Netherlands
Novartis Pharmaceuticals

Completed

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C (ORION-14)

Hyperlipidemia

China
Organon and Co

Completed

A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)

Spondylitis, Ankylosing
Purdue University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of Food Form on Cephalic Phase Responses

Overweight | Obese

United States
IRCCS San Raffaele

Completed

Protective Ventilation in Neurosurgery, a Pilot Study (NeuroVentOR)

Nervous System Neoplasms

Italy
Facultad Nacional de Salud Publica

Unknown

Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment

Aggressive Periodontitis

Colombia
Global Alliance for TB Drug Development

Completed

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Pulmonary Tuberculosis

Tanzania, South Africa
Novartis Pharmaceuticals

Completed

A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease

Alzheimer's Disease

China
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

Healthy

Germany
Panhandle Eye Group, LLP

Suspended

Intracameral Antibiotic Safety Study

Endophthalmitis | Cataract Surgery | Phacoemulsification | Vancomycin | Intracameral Antibiotics | Moxifloxacin

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

Healthy Subjects

United States
Centre Oscar Lambret
National Cancer Institute, France; Aix Marseille Université; University of Paris... and other collaborators

Unknown

Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer (KALICOU3)

Breast Cancer | Aging

France
Zhiming Zhu

Completed

Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive (ESTAB)

Prehypertension

China
Minnesota Department of Health

Completed

Factorial Design to Assess Quit-line Connections

Smoking Cessation

United States
Ionis Pharmaceuticals, Inc.
Akcea Therapeutics

Completed

A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

Abnormalities, Cardiovascular

United States
Poxel SA

Completed

Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

Qt Interval, Variation in

United Kingdom
Cargill
Ajinomoto Co., Inc.

Completed

Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects

Cardiovascular Abnormalities
Novartis Pharmaceuticals

Completed

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure (ESCAPE-SHF)

Heart Failure

Russian Federation, Germany, Poland
University of Florida
National Institutes of Health (NIH); National Institute on Deafness and Other...

Withdrawn

Laryngeal Adaptation for Speech and Swallowing

Stroke | Dysphagia | Spinocerebellar Ataxia | Dysarthria | Cerebral Stroke
Lundquist Institute for Biomedical Innovation at...
Abbott Nutrition; DaVita Dialysis

Completed

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients (AIONID)

Inflammation | Oxidative Stress | Hypoalbuminemia | Protein-energy Malnutrition | Chronic Kidney Disease (CKD) Hemodialysis

United States
Amgen

Completed

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States, Italy, Netherlands, Canada, United Kingdom, Australia, Germany, Czechia, Greece, France
GlaxoSmithKline

Completed

Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza

Virus Diseases

United States, South Africa, Australia
Gilead Sciences

Completed

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Hepatitis C, Chronic

United States, Germany

Search clinical trials for: Placebo to moxifloxacin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations